Free Communications - HPV Testing + Genotyping

9:45 AM • FC 22-01 • Identifying the causal HPV genotypes in high-grade cervical lesions using HPV genotyping of cervical screening samples > B. Birgit Lissenberg-Witte 9:57 AM • FC 22-02 • Assessment of attribution algorithms for resolving CIN3-related HPV genotype prevalence in mixed-genotype biopsy specimens using laser capture microdissection as the reference standard > S. Suzanne Garland 10:09 AM • FC 22-04 • Clinical validation of the full genotyping CLART4S HPV assay on SurePath collected screening samples according to the international guidelines for human papillomavirus test requirements for cervical screening > D. Ditte Møller Ejegod 10:21 AM • FC 22-05 • Systematic literature review on triage strategies for HPV positive and ASCUS/LSIL patients: role of extended HPV genotyping vs other triage methods > D. Douglas Malinowski 10:33 AM • FC 22-06 • The role of HPV genotyping in post-treatment follow-up of cervical intraepithelial neoplasia > A. ANNA DANIELA Iacobone 10:45 AM • FC 22-07 • Prevalence and genotype distribution of non HPV-HR types in women with high grade cervical lesions in Northern area in Israel > L. Lena Mackuli 10:57 AM • FC 22-08 • Comparison of partial HPV genotyping using the Cobas 4800 HPV test and the Aptima HPV 16 18/45 genotype assay > C. Christine White